Accordant Medical Management
Download
Report
Transcript Accordant Medical Management
Steven K. Schelhammer
Founder and President
Managing
Costly
Chronic
Conditions
Through Integrated
Disease Management
©2003 Accordant
Managing Costly Chronic Conditions
Agenda
Costly chronic conditions
Specialized disease management
Predictive modeling
Integrated care
Care coordination
Interventions
Results
©2003 Accordant
Costly Chronic Conditions
Examples of Their Direct Impact on Spend
Rheumatoid Arthritis
$15,000 +
Gaucher Disease
$250,000
Multiple Sclerosis
$15,000
Hepatitis C
$24,000
Specialty
Drug
Costs
Oncology,
BMT HIV/AIDS
$5,000-10,000
Pulmonary Hypertension
$30,000 -100,000
Growth Hormone Deficiency
$18,000
Per Patient
Per Year
Hemophilia
$200,000 +
Infertility
$18,000-20,000
©2003 Accordant
Costly Chronic Conditions
Are Complex, Unique and Progressive
Require:
Specialized expertise
Patient self-management
Dynamic interventions to meet varying complications
Support to prevent crises
Result in:
High costs for inpatient hospitalization
Expensive specialty drugs utilization
Patient identification difficulty, due to many false positives
Progression of expense over time
©2003 Accordant
Costly Chronic Conditions
Significant Total Cost Trend For Conditions
15%
Medical cost increases for unmanaged
chronic diseases average 15.6 percent,
surpassing the rate of inflation
9.6%
10%
6.9%
5.7%
$1,200
$900
$600
CMSReported
Inflation
5%
$1,500
$300
Avg. PMPM Chronic Diseases
20%
$0
0%
1999
Source: Accordant Health Services, Inc.
2000
2001
©2003 Accordant
Specialized DM:
Solution
Improves health and lower costs, through:
Predictive modeling
– Supports patient identification
Case management
– Nurses provide patient education and compliance
monitoring
Disease management expertise
– Serving patients with chronic, complex, progressive
diseases
Specialty pharmacy services
– Integrated workflow, reporting and intervention
©2003 Accordant
Specialized DM: Predictive Modeling
Leads a Targeted Approach
Why predictive modeling?
Use when the correlation between near-term costs and
disease diagnosis is weak, like COPD, diabetes or asthma
But, predictive modeling is not enough …
Standard predictive models can’t identify complex,
chronic patients
For example, one client’s former predictive modeling
vendor was only able to identify 161 of over 1,900 highcost patients
For co-hort of Accordant diseases, the diagnosis
IS the prediction of high-cost patients
©2003 Accordant
Specialized DM: Predictive Modeling
Population Management
100%
70% of
today’s
high-cost
patients
were not
high-cost
2 years
ago
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Cost Status 2 Years Prior
Cost Status 6 Months Prior
Highest Cost
Middle Cost
Highest Cost Status
Lowest Cost
Note: Population migration analysis, AHS vs. MCO. Figure shows percent of population at or above
the “top” cost threshold.
©2003 Accordant
Specialized DM: Predictive Modeling
A 24-month Cost Threshold
100
Unmanaged:
95% of Patients
Exceed the 90th
Cost Percentile
90
80
70
60
50
For Accordant
diseases, diagnosis is
the best predictor of
future near-term costs
Patients exceed 90th
cost percentile
40
30
20
8 months, on average
10
0
Patients
Exceeding
Threshold
Source: AHS-MCO-011113
Patients Not
Exceeding
Threshold
Based on 24-month
continuous enrollment
©2003 Accordant
Specialized DM: Integrated Care
Address entire
condition and its
typical course with
population-based
approach to:
Population DM opportunity
PMPM
Least
Costly
Most
Costly
Minimize the magnitude
of acute events and
high cost cases
Reduce the frequency
of predictable events
and high-cost cases
Every patient with
the condition is eligible
©2003 Accordant
Opportunity for Specialty Pharmacy
Integration Benefits
Information flow from typical Specialty Rx vendors
Accordant Health Services DM Coordination
MCO
Info
Patient
Info
Physician
Info
Solid Bidirectional
Information Flow
Incompatible Systems
Mis-Aligned Incentives
Homecare
Info
As-Needed
Information Flow
Provider
Info
Specialty
Pharmacy
Info
Nonexistent
or One-Way
Information Flow
Operational Priorities
Competitive Concerns
©2003 Accordant
Accordant DM with AdvancePCS
Specialty RX
Better Communication and Service
DM Coordination
MCO
Info
Patient
Info
Physician
Info
Solid Bidirectional
Information Flow
Compatible Systems
Aligned Incentives
Homecare
Info
As-Needed
Information Flow
Provider
Info
Specialty
Pharmacy
Info
Solid
Bi-directional
Information Flow
Consistent Operational Priorities
No Competitive Concerns
©2003 Accordant
Specialized DM: Integrated Care
with Specialty Pharmacy
Increases program savings by an additional 20%
and ROI by 40%
Greater control over specialty drug spend with patient
steerage and standard therapy guidelines
Enhanced patient services with single point of contact
More effective real-time interventions
Example
A large health plan client
Implemented integrated specialty pharmacy service
Realized $600K in savings to date
On track for an additional 20% savings
©2003 Accordant
Specialized DM: Care Coordination
Benefits review
Facilitation between patient, physician, health plan
and vendors
Coordination includes home infusion and
therapies, DME, PT, OT
Same benefits review, coordination, facilitation
with comorbid conditions, as with the DM program
they are enrolled in
©2003 Accordant
Specialized DM: Care Coordination
with Physicians
Offers physician support in caring
for patients
Highly trained and experienced
patient support partner
Helps promote treatment compliance
Coordinates an array of complex
care and services that ordinarily
bewilder patients
Improves health outcomes by
providing additional service and
support to the physician
©2003 Accordant
Specialized DM: Interventions
Research & Development
Research natural history of the disease and
develop construct
Identify and rank significant complications and
their associated costs
Baseline cost analysis
Assess significant risks and match proven
strategies to prevent problems and complications
Medical guideline: Strategy-intervention grid
©2003 Accordant
Specialized DM: Interventions
Preventing Complications
Risk stratification, each with their own interventions
Multiple sclerosis:
– Exacerbations
– UTI
– Falls with fractures
– Skin breakdown
Rheumatoid arthritis:
– Flares
– Infections
– Falls with fractures
– GI bleeding
Assess and monitor closely
©2003 Accordant
Specialized DM: Interventions
Promoting Patient Self-Management
Access to general information and assessments
Education about disease, medications and
therapies
Better communication with the health care team
Compliance with the treatment plan
Skills development assistance including coping,
lifestyle and service coordination
©2003 Accordant
Specialized DM: Interventions
Data Analysis
Analysis of integrated claims and patient-reported
data on MS flares
Findings:
– Antidepressant users were 3 times more likely to have
a flare
– Patients with a concurrent infection are 1.5 times more
likely to have a flare
– Incidence and frequency of flares are related to
disease progression
Results:
– Investigating the link between these associations and
flares
©2003 Accordant
Specialized DM: Intervention Example
Promoting Better Self-Management Skills for MS
Goal: Decrease admissions to hospital for urinary tract infection
and Pyelonephritis -- Ranked # 2 for hospital admissions
Assess patient’s knowledge of:
UTI and its major symptoms
Symptoms of spastic “neurogenic” bladder
What to do if they develop acute Sx’s
Intervene with:
Education
Assessment of clinical status
Facilitate appointments with physician,
Alert the physician of acute symptoms and untreated spastic neurogenic
bladder
Guidelines: American Academy of Neurology and NMSS
©2003 Accordant
Specialized DM: Intervention Example
Falls with Fractures are Common for RA Patients
Goal: Decrease falls and fractures that lead to hospitalization
Assess:
Risk of falls with mobility scales such as HAQ for rheumatology
conditions.
Individual risks (lives alone, frequent trips to bathroom, etc)
Risk of osteoporosis (steroids, cytotoxic drugs)
Intervene with:
Education to prevent falls
Arrange home safety evaluation
Education about use of Calcium and Vitamin D
Alert physician for preventive medications for osteoporosis
Monitor for compliance with medications
Guidelines: American Academy of Rheumatology, Osteoporosis Foundation
©2003 Accordant
Specialized DM: Intervention Example
Overutilization Among Hemophilia Patients
Goal: Reduction of product overutilization
Manage by:
Preventing bleeding episodes
Minimizing the number of treatments needed to stop a bleed
Monitoring inventory/deliveries compared to prescription
Providing competitively priced products with aligned incentives
Intervene with:
Patient education
Behavior modification
Competitively-priced fulfillment of factor concentrates
Guidelines: Hemophilia Treatment Center/National Hemophilia Foundation
©2003 Accordant
Specialized DM: Intervention
Promoting Drug Safety
Proactive interventions (education)
Patient pharmacy communications
Safe medicine practice at home
Safe medicine practice at hospital
Reactive intervention (monitoring)
Drug interactions
Contraindicated drugs
Medication duplications
©2003 Accordant
Results: Value
Ensuring That Myasthenia Gravis Patients
Carry a List of Contraindicated Drugs
MG-3
Percent Carrying AHS Medication List
Source: Assessment Data through 6/30/2002 (95% CI Shown)
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
1
2
3
4
5
6
7
8
Length of Time in Program (LOTIP) by Qtr
©2003 Accordant
Results: Value
PMPM
Comparing Pre and Post Cost Trends PMPM
Preprogram PMPM cost
Post program PMPM cost
Based on a specific
client experience.
Claims incurred
through May 31 2002
Length of Time in Program (LOTIP) Monthly
Eligible members - Excluding members that have died, members for whom coverage is secondary, and members covered
by another disease management organization. All Diseases
©2003 Accordant
Results: Value
Utilization
Comparing Preprogram Hospital Admit Costs
Based on a specific
client experience.
Claims incurred
through May 31 2002
Preprogram hospital admits / 100
Post program cost / 100
LOTIP: Length Of
Time In Program
Length of Time in Program (LOTIP) monthly
Eligible members - Excluding members that have died, members for whom coverage is secondary, and
members covered by another disease management organization. All Diseases
©2003 Accordant